Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Larson

Showing results (51-60 of 300) with videos related to

Pageof 30
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2003
Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PETHenry W D Yeung, Ravinder K Grewal, Mithat Gonen, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
PET Scanning with (18)F 2-Fluoro-2-Deoxy-D-Glucose (FDG) in Patients with Melanoma. Benefits and LimitationsAn T. Nguyen, Tim Akhurst, Steven M. Larson, et al.
Current Oncology Reports|August 5, 2003
New strategies in radioimmunotherapy for lymphomaNeeta Pandit-Taskar, Paul A Hamlin, Susan Reyes, et al.
Frontiers in Oncology|October 12, 2020
CAR Chase: Where Do Engineered Cells Go in Humans?Simone Krebs, Megan M Dacek, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Peritoneal carcinomatosis: role of (18)F-FDG PETAlla Turlakow, Henry W Yeung, Aida Sanchez Salmon, et al.
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Developing imaging strategies for castration resistant prostate cancerJosef J Fox, Michael J Morris, Steven M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal doseGregor J Förster, Elmer B Santos, Peter M Smith-Jones, et al.
Cancer|May 20, 2008
Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinomaMichael Rivera, Ronald A Ghossein, Heiko Schoder, et al.
Prostate Cancer and Prostatic Diseases|May 1, 2019
Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trialsJose Mauricio Mota, Andrew J Armstrong, Steven M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PETJen-Chieh Tseng, Pat B Zanzonico, Brandi Levin, et al.
Pageof 30

Showing results (51-60 of 300) with videos related to

Sort By:
Pageof 30
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2003
Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PETHenry W D Yeung, Ravinder K Grewal, Mithat Gonen, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
PET Scanning with (18)F 2-Fluoro-2-Deoxy-D-Glucose (FDG) in Patients with Melanoma. Benefits and LimitationsAn T. Nguyen, Tim Akhurst, Steven M. Larson, et al.
Current Oncology Reports|August 5, 2003
New strategies in radioimmunotherapy for lymphomaNeeta Pandit-Taskar, Paul A Hamlin, Susan Reyes, et al.
Frontiers in Oncology|October 12, 2020
CAR Chase: Where Do Engineered Cells Go in Humans?Simone Krebs, Megan M Dacek, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Peritoneal carcinomatosis: role of (18)F-FDG PETAlla Turlakow, Henry W Yeung, Aida Sanchez Salmon, et al.
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Developing imaging strategies for castration resistant prostate cancerJosef J Fox, Michael J Morris, Steven M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal doseGregor J Förster, Elmer B Santos, Peter M Smith-Jones, et al.
Cancer|May 20, 2008
Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinomaMichael Rivera, Ronald A Ghossein, Heiko Schoder, et al.
Prostate Cancer and Prostatic Diseases|May 1, 2019
Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trialsJose Mauricio Mota, Andrew J Armstrong, Steven M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PETJen-Chieh Tseng, Pat B Zanzonico, Brandi Levin, et al.
Pageof 30